139 related articles for article (PubMed ID: 1508841)
1. Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.
Yasumasu T; Ueda T; Uozumi J; Mihara Y; Kumazawa J
Pharmacol Toxicol; 1992 Feb; 70(2):143-7. PubMed ID: 1508841
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural alterations and DNA synthesis of renal cell nuclei following cisplatin or carboplatin injection in rats.
Yasumasu T; Ueda T; Uozumi J; Mihara Y; Koikawa Y; Kumazawa J
J Pharm Pharmacol; 1992 Nov; 44(11):885-7. PubMed ID: 1361530
[TBL] [Abstract][Full Text] [Related]
3. Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats.
Wolfgang GH; Dominick MA; Walsh KM; Hoeschele JD; Pegg DG
Fundam Appl Toxicol; 1994 Jan; 22(1):73-9. PubMed ID: 8125216
[TBL] [Abstract][Full Text] [Related]
4. Experimental studies on the pharmacokinetics and nephrotoxicity of carboplatin (cis-diammine-1, 1-cyclobutane dicarboxylate platinum II) in rats.
Ueda T; Yasumasu T; Uozumi J
J Toxicol Sci; 1991 Aug; 16(3):101-9. PubMed ID: 1942134
[TBL] [Abstract][Full Text] [Related]
5. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
Hanada K; Asano K; Nishimura T; Chimata T; Matsuo Y; Tsuchiya M; Ogata H
J Pharm Pharmacol; 2008 Mar; 60(3):317-22. PubMed ID: 18284811
[TBL] [Abstract][Full Text] [Related]
6. Tissue injury and repair in the rat kidney after exposure to cisplatin or carboplatin.
Nonclercq D; Toubeau G; Laurent G; Tulkens PM; Heuson-Stiennon JA
Exp Mol Pathol; 1989 Oct; 51(2):123-40. PubMed ID: 2680578
[TBL] [Abstract][Full Text] [Related]
7. Comparative nephrotoxicity of carboplatin and cisplatin in euvolemic and dehydrated rats.
Martinez F; Deray G; Dubois M; Beaufils H; Jacquiaud C; Bourbouze R; Benhmida M; Jaudon MC; Jacobs C
Anticancer Drugs; 1993 Feb; 4(1):85-90. PubMed ID: 8457719
[TBL] [Abstract][Full Text] [Related]
8. The relative nephrotoxicity of cisplatin, cis-[Pt(NH3)2(guanosine)2]2+, and the hydrolysis product of cisplatin in the rat.
Jones MM; Basinger MA; Beaty JA; Holscher MA
Cancer Chemother Pharmacol; 1991; 29(1):29-32. PubMed ID: 1742846
[TBL] [Abstract][Full Text] [Related]
9. Differential toxicity of cisplatin, carboplatin, and CI-973 correlates with cellular platinum levels in rat renal cortical slices.
Leibbrandt ME; Wolfgang GH
Toxicol Appl Pharmacol; 1995 Jun; 132(2):245-52. PubMed ID: 7785052
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system.
Stöhr W; Paulides M; Bielack S; Jürgens H; Koscielniak E; Rossi R; Langer T; Beck JD
Pediatr Blood Cancer; 2007 Feb; 48(2):140-7. PubMed ID: 16724313
[TBL] [Abstract][Full Text] [Related]
11. Time response of carboplatin-induced nephrotoxicity in rats.
Husain K; Whitworth C; Rybak LP
Pharmacol Res; 2004 Sep; 50(3):291-300. PubMed ID: 15225673
[TBL] [Abstract][Full Text] [Related]
12. Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats.
Ormond PM; Basinger MA; Jones MM; Hande KR
J Pharmacol Exp Ther; 1992 Jul; 262(1):246-51. PubMed ID: 1385629
[TBL] [Abstract][Full Text] [Related]
13. Renal tissue injury and proliferative response after successive treatments with anticancer platinum derivatives and tobramycin.
Nonclercq D; Toubeau G; Tulkens P; Heuson-Stiennon JA; Laurent G
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(3):143-58. PubMed ID: 1980761
[TBL] [Abstract][Full Text] [Related]
14. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
[TBL] [Abstract][Full Text] [Related]
15. The effect of sodium thiosulfate on subcellular localization of platinum in rat kidney after treatment with cisplatin.
Uozumi J; Litterst CL
Cancer Lett; 1986 Sep; 32(3):279-83. PubMed ID: 3768854
[TBL] [Abstract][Full Text] [Related]
16. Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin.
Bregman CL; Williams PD
Cancer Chemother Pharmacol; 1986; 18(2):117-23. PubMed ID: 3539384
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic effect of methylprednisolone against cisplatin-induced nephrotoxicity in rats.
Koikawa Y; Uozumi J; Ueda T; Yasumasu T; Kumazawa J
Toxicol Lett; 1993 Mar; 66(3):281-5. PubMed ID: 8475508
[TBL] [Abstract][Full Text] [Related]
18. Comparative nephrotoxicity of tetraplatin and cisplatin in rats.
Rahman A; Roh JK; Preuss HG
Nephron; 1993; 64(2):289-95. PubMed ID: 8321364
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and toxicodynamics of cisplatin and its metabolites in rats: relationship between renal handling and nephrotoxicity of cisplatin.
Hanada K; Ninomiya K; Ogata H
J Pharm Pharmacol; 2000 Nov; 52(11):1345-53. PubMed ID: 11186242
[TBL] [Abstract][Full Text] [Related]
20. The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats.
Uozumi J; Litterst CL
J Pharmacobiodyn; 1988 Apr; 11(4):277-83. PubMed ID: 3411443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
